中泰国际每日晨讯-20251222

Market Performance - Last week, Hong Kong stocks showed a rebound, with the Hang Seng Index, the Hang Seng China Enterprises Index, and the Hang Seng Tech Index rising by 0.8%, 0.7%, and 1.1% respectively[1] - Large insurance and domestic bank stocks performed steadily in the latter half of the week, supporting the market's recovery[1] - The pharmaceutical sector saw a rebound after the U.S. Senate passed the revised 2026 National Defense Authorization Act, benefiting companies like WuXi Biologics and WuXi AppTec[1] Sector Highlights - The automotive sector rebounded significantly, with XPeng Motors rising by 7.6% after receiving an L3 autonomous driving road test license in Guangzhou[4] - The healthcare sector's Hang Seng Medical Care Index fell by 1.8% overall but rose by 1.7% on Friday, indicating a potential recovery[5] - The renewable energy and utilities sectors experienced a general decline, although the photovoltaic sector saw slight gains due to expected policy support[6] Economic Indicators - The U.S. Michigan Consumer Sentiment Index for December was reported at 52.9, below Bloomberg's forecast of 53.5 but above the previous value of 51.0[3] Investment Opportunities - The upcoming IPO of Insilico Medicine, a prominent AI-driven drug discovery company, is noteworthy due to its rapid revenue growth and strong backing from reputable investors[5] - The recent policy on e-cigarette regulation is expected to create new opportunities for compliance-driven growth in the domestic market[1]